- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 07.07. | Bristol lays out KRAS med Krazati's stumble in confirmatory colorectal cancer trial | ||
| 07.07. | On heels of Bain buyout, Tanabe inks deal to sell manufacturing unit and 17 drugs to Towa | ||
| 07.07. | Vertex, in its largest-ever deal, acquires endocrine disease specialist Crinetics for $10B | ||
| 07.07. | Real Chemistry snaps up Spurwing Communications, launches new Asia Pacific hub | ||
| 07.07. | Skin quality driving widespread quality-of-life issues: survey | ||
| 06.07. | FDA deepens Vertex's Casgevy label, opening treatment for patients as young as 2 | ||
| 06.07. | Amgen issues recall for close to 1M heart med bottles due to contamination | ||
| 01.07. | Lonza expands partnership with US drugmaker, boosts capacity for ADCs | ||
| 01.07. | Sanofi unit in Ireland chided by FDA over manufacturing flubs linked to Altuviiio | ||
| 01.07. | Regulatory tracker: FDA sets decision date for Sarepta's DMD drugs | ||
| 01.07. | BridgeBio attracts $1B in equity for new launches, but analyst smells M&A 'dry powder' | ||
| 01.07. | Kimball lays out $103M to bolster life sciences CDMO footprint across Europe, India | ||
| 01.07. | Haleon teams up with Microsoft in 5-year AI pact to upgrade consumer health operations | ||
| 01.07. | Plus Therapeutics rebrands as Cerenome as it deepens AI strategy | ||
| 01.07. | Orca Bio makes a splash with FDA approval for cell therapy Tregzi. Could an IPO come next? | ||
| 30.06. | AstraZeneca agrees to pay $34M to settle 'free nurses' kickback lawsuit from Texas | ||
| 30.06. | Rising Stars: How Novo Nordisk's Tara Sparks Went from Super Bowl Fan to Super Bowl Marketer | ||
| 30.06. | Medical journal retracts Tavneos pivotal study article, complicating Amgen's defense effort | ||
| 30.06. | After monotherapy failure, AbbVie and Genmab tout Epkinly combo win in DLBCL | ||
| 30.06. | FDA selects Lilly, Regeneron, Fujifilm, 4 others for PreCheck Pilot Program | ||
| 30.06. | Unicycive turned away by FDA again over manufacturer's plant shortfalls | ||
| 29.06. | Zymeworks acquires struggling Theravance for $929M | ||
| 29.06. | FDA rejects Sobi's gout drug over manufacturing issues, sparing Amgen blockbuster | ||
| 29.06. | Look out, Amgen. Here comes Viridian with FDA nod for TED med Lumvoa | ||
| 26.06. | FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.